ADEST: Clinical Evaluation of the concommitant use of Bivalirudin (Angiomax™) and a Drug Eluting Stent

Study of:
Bivalirudin (a blood thinning drug)

This multi-center, non-randomized study will evaluate the clinical use of Bivalirudin (a blood thinning drug) administered during stent assisted percutaneous coronary intervention using the Cyper™ Sirolimus-eluting stent. This study will enroll 1,175 subjects at site sites in the United States. Follow-up will include a 30-day phone call.

• Timothy D. Henry, MD, FACC

• M. Nicholas Burke, MD
• Ivan J. Chavez, MD, FACC
• John R. Lesser, MD, FACC
• Daniel Lips, MD, FACC
• James D. Madison, MD, FACC
• Michael R. Mooney, MD, FACC
• Wesley R. Pedersen, MD, FACC
• Anil K. Poulose, MD, FACC
• Jay H. Traverse, MD, FACC, FAHA
• Yale Wang, MD, FACC, FSCAI

• Talia Pierce, RN

For more information about this study or the Interventional Cardiology Research program at the Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, please contact Carol Stone at 612-863-9124